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Processing
Visual Info mation 
At a demonstratio" organized by animal rights activists on May 1, supporters of humane and ethical 
animal research outnumbered their opponents. Supporters of animal research can-ied signs to remind 
the public of the many conditions that animal research has helped medical science to understand and 
control. The demonstrations, held at the Medical Center. were vocal but peacefuL 
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On The Cover: 
A computer-generated view of the 
macaque vi sual system; structures 
related to vision are depicted in 
color. Research under the direction 
of David C. Van Essen, Ph.D., head 
of the Department of Anatomy and 
Neurobiology, explores informa­
tion processing in the primate'S 
visual system. Photograph by Tom 
Heine. Story on page 12. 
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Unraveling the complicated means by which 
we see. 
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n mid-May, David 
Schlessinger, Ph.D., and 
his colleagues in St. 
Louis hosted nearly 100 sci­
entists at the international 
4th X Chromosome Work­
shop. 
From arollnd the world, 
researchers with interests in 
the human X chromosome 
gathered at the Ritz-Carlton 
Hotel in Clayton to exchange 
information, visit computer 
demonstrations, view poster 
sessions and hear more for­
mal presentations. 
In addition, a huge bulle­
tin board carried a likeness 
of the X chromosome, and 
researchers were encouraged 
to fi II in the blanks with in­
formation they had discerned 
in their investigations. The 
St. Louis group, one of the 
world's most active, added 
contributions that have 
helped to organize more than 
80 percent of the chromo­
some into mapped regions. 
A week after the X chro­
mosome workshop, Eric D. 
Green, M.D., Ph.D. , was in 
Marburg, Germany, helping 
to chair the first workshop 
for researchers studying hu­
man chromosome 7. 
Along with co-organizers 
from Canada and Germany, 
Green hosted 50 researchers 
from around the world . The 
group shared information 
concerning the techniques 
their labs employ to map the 
chromosome, the maps they 
have produced and the re­
agents that they use . • 
Shuly Dt'fin("~ Call~e Of 

Diah(~te~ Subtype 
Researchers here have identified 16 gene mutations respon­
sible for causing a subform 
of adult-onset diabetes. The 
study provides the most 
complete explanation to date 
of the cause of any form of 
diabetes and is the most 
thorough investigation of 
any gene's role in the dis­
ease. 
"For the first time we 
clearly know the cause of 
diabetes in a subset of these 
patients , " says Alan Per­
mutt, M.D., professor of 
medicine. Permutt ' s labora­
tory conducted the study 
with collaborators from the 
University of Chicago and 
the Centre d' Etude 
Polymorphisme Humain in 
Paris. Genetic discoveries 
such as these may eventually 
lead to gene therapies and to 
genetic tests that predict dia­
betes in non-symptomatic 
people, he adds. 
The researchers looked 
for mutations in the gene for 
glucokinase, an enzyme 
thought to be critical for 
stimulating pancreatic insu­
lin secretion. A few muta­
tions in this gene have been 
reported in past studies, Per­
mutt explains, but were 
found in only four families. 
This study looked at a large 
group of diabetic families to 
find a more definitive expla­
nation of the role glucoki­
nase mutations play in the 
development of adult-onset 
diabetes, also called Type II 
diabetes. 
Using DNA isolated from 
blood cells, the investigators 
studied 53 French families 
- 21 with Type Tl diabetes 
and 32 with a Type [[ 
subform called maturity-on­
set diabetes of the young 
(MODY), Permutt says. 
Type II diabetes is the most 
common form of the disease 
and affects about J2.5 mil­
lion Americans. It normally 
appears in middle age and is 
characterized by the inabi Iity 
to produce enough insulin or 
to respond properly to insu­
[in. MODY is a subform in 
which symptoms appear be­
fore age 25. It accounts for 
about five percent of Type II 
cases. 
Researchers found 16 mu­
tations in [8 (56 percent) of 
the MODY families and no 
mutations in any of the other 
families. ln addition , they 
found that patients with glu­
cokinase mutations were di­
agnosed earlier in childhood 
and were more mildly af­
fected than MODY patients 
with normal glucokinase 
genes. Their findings imply 
that - at least in this study 
population - the glucoki­
nase gene is the primary 
cause of MODY and prob­
ably does not play an impor­
tant role in causing 
non-MODY cases of Type II 
diabetes. 
Although it is likely that 
similar mutations will be 
David Schlessinger, Ph.D., and research associate Gina 
Penglle examine one ofthe postings at the recent 4th X 
Chromosome Workshop, held in St. LOllis. 
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found in other racial and eth­
nic groups, additional studies 
will be needed to clarify the 
glucokinase gene's role out­
side of this study population, 
Permutt cautions. He cur­
rently is studying the glu­
cokinase gene in African 
Americans and Mauritian 
Creoles. In addition to glu­
cokinase mutations, genetic 
studies have linked MODY 
diabetes to an unknown gene 
on chromosome 20, Permutt 
says. • 
lVlalaria 
. ~Para!"lile ~ 
F ecdinn' l'"'I 
Tllht~ FOIllul 
R esearchers have found a molecular "feeding tube" that 
may be critical to the malaria 
parasite's survival in human 
red blood cells. The mol­
ecule is an ion channel that 
allows essential nutrients to 
pass from the red blood cell 
into the parasite, investiga­
tors report. 
"This seems to be a mol­
ecule that is involved in the 
parasite's eating behavior, 
and it may be necessary for 
the parasi te to live. So even­
tually it could be a target for 
the development of drugs to 
s tarve malaria," says Edwin 
McCleskey, Ph.D., associate 
professor of cell biology and 
physiology. 
The malaria parasite 
spends part of its complex 
life cycle inside human red 
blood cells, McCleskey ex­
plains. There, it exists en­
cased in two membranes: 
One is its own, and the other 
is a sac formed around the 
parasite from the red blood 
cell's membrane. The para­
site multiplies inside the red 
cell for two days, then bursts 
out, sending roughly 32 new 
parasites into the blood to 
infect 32 more red cells. 
While in red cells, the 
organism uses hemoglobin 
In this oscilloscope tracing, each downward deflection from 
the topmost horizontal represents the opening ofa single ion­
channel feeding tube in a malaria parasite. Three feeding 
tubes h(IVe been isoLated, each capable of transporting a mil­
lion ions per second. The activity is determined electrically, 
with the difference between open and closed equal to about 5 
x 1ft/} (Imps. One amp is roughly eql/alto the current re­
quired by a light bulb. 
as its main food source. "But 
it also needs glucose and 
some amino acids that are 
not present in hemoglobin. 
So it has to come up with 
ways to get these foods, and 
everything it eats has to 
come through the red blood 
cell ," McCleskey says. Unti I 
now, there was no explana­
tion for how such nutrients 
actually crossed the double 
barrier. 
The investigators found 
several unusual characteris­
tics of the new channel that 
suggest it plays a role in 
feeding, he says. Typically, 
ion channels are extremely 
selective; they allow only 
very small particles of a cer­
tain charge to pass through . 
But the parasite ' s channels 
are permeable to both posi­
tive and negative ions, as 
well as organic molecules 
too large to pass through 
most channels, the investiga­
tors found. 
The next step, McCleskey 
says, is to find an easier way 
to study the channel. Studies 
to understand the biology of 
the malaria parasite are es­
sential because 5,000 people 
a day die from the disease 
worldwide, McCleskey says. 
Most deaths result from one 
parasite species that is resis­
tant to the most important 
malarial drug, chloroquine. 
"So we do need additional 
drugs or a vaccine . We try to 
describe the biology of the 
parasite to find molecules 
that are essential for it to live 
and then design drugs to 
knock those molecules out," 




T he Burroughs Wellcome Fund has named David H. 
Perlmutter, M.D., one of two 
recipients of the Experimen­
tal Therapeutics Scholar 
Award for 1993. The awards 
of $350,000, payable over 
fi ve years, encourage the 
development of outstanding 
clinical scientists dedicated 
to closing the gap between 
the basic sciences and their 
application to clinical medi­
cine. 
The award is for work in 
the Perlmutter laboratory 
showing that a specific cell 
surface receptor for alpha-l­
antitrypsin-protease com­
plexes, the SEC receptor, 
also recognizes the beta­
amyloid peptide. The beta­
amyloid peptide accumulates 
in the brains of patients with 
Alzheimer 's disease and has 
been linked to dementia in 
those patients. The SEC re­
ceptor may therefore be an 
excellent target of novel 
pharmacologic approaches 
for treatment of Alzheimer's. 
Perlmutter's lab also stud­
ies the biochemistry of a 
genetic deficiency of alpha­
I-antitrypsin, the most com­
mon metabolic cause of liver 
disease in infants and the 
most common metabolic 
cause of emphysema in 
adults . • 
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Ahdull1inal ()hesiLy Linked To Diaht"le~ 

Abdominal obesity appears to be a stron­ger factor than age in 
the development of adult­
onset diabetes in older 
adults, according to re­
searchers here. 
Investigators studied 67 
men and women aged 60 to 
70 to find out whether aging 
or belly fat is a bigger factor 
in the decline that occurs in 
the body's ability to regulate 
blood sugar levels as age 
advances. 
The inability to regulate 
blood sugar, known as glu­
cose intolerance, develops 
when the body becomes re­
sistant to the actions of insu­
4 
lin, the hormone responsible 
for lowering blood sugar lev­
els. 
Subjects were evaluated 
for body fat distribution, 
level of physical fitness, glu­
cose tolerance and insulin 
resistance. Forty-three sub­
jects who had varying de­
grees of insulin resistance 
were found to be signifi­
cantly bigger around their 
chest, waist, and hips. Re­
searchers found that when 
the effects of varying waist 
circumference were statisti­
cally controlled, other fac­
tors - such as age, fitness 
level, total body fat and the 
waist-to-hip circumference 
ratio - did not explain the 
inability to regulate blood 
sugar level. 
"Basically, if we take any 
measurements in the trunk 
region, those who have im­
paired glucose tolerance and 
insulin resistance tend to 
show more central adiposity 
(fat)," says Wendy M. Kohrt, 
Ph.D., research assistant pro­
fessor and principal investi­
gator. "We found the same 
held true in both men and 
women." 
Blood glucose levels are 
held in check by insulin, the 
hormone secreted by the 
body to clear glucose from 
the blood into muscles, 
where it is stored for energy. 
With advancing age, Kohrt 
says, insulin produced isn't 
as effective in controlling 
blood sugar. To offset higher 
sugar levels, the body often 
compensates by secreting 
more insulin. As a result, 
Kohrt says, many older 
people with high blood sugar 
levels also have high insulin 
levels that can make them 




"Our study cannot rule 
out the possibi Iity that there 
is a decline in glucose toler­
ance associated with the ag­
ing process," says Kohrt. "It 
does suggest, however, that 
many of the changes that 
have been attributed to aging 
are the result of changes in 
regional adiposity, which is 
probably secondary to the 
decline in physical activity 
that frequently accompanies 
aging. The good news is that 
it's something that is very 
amenable to change through 




Tl'ainiuu PET ~ 
Expert~ 
A s part of the Dana Foundation's recently announced $25 mil­
lion commitment to a con­
sortium on memory loss and 
aging, physicians here and at 
UCLA have been named to 
train a cadre of specialists in 
positron emission tomogra­
phy (PET) imaging of the 
human brain. 
The foundation is bring­
ing advances in neuroscience 
to an understanding of the 
brain and the treatment of 
brain-related diseases. PET 
will playa key role in ad­
vancing understanding of the 
biology of the brain by al­
lowing noninvasive imaging 
of healthy and diseased 
brains, making it possible to 
distinguish between healthy 
brain function and the meta­
bolic impact that occurs as 
diseases interfere with nor­
mal brain function. Among 
the first research efforts sup­
ported by the foundation will 
be a focus on the biology of 
memory loss and aging. 
Marcus E. Raichle, M.D., 
professor of neurology and 
of radiology, will coordinate 
In a study ofabdominal obesity and adult-onset diabetes, 
both men and women with insulin resistance were found to 
have increased central adiposity. Here, Wendy ill. Kohrt, 
Ph.D., measures Benjamin Jenkins. 
the training of leaders in 
PET technology here under 
an initial grant of$I.7 mil­
lion. The grant can be ex­
panded to a total of $3 
million over five years. PET, 
which images the body's 
functions rather than just its 
form, provides vivid pictures 
of reactions in the areas of 
the brain devoted to emotion, 
language and the forming 
and storing of memories. 
Developed at Washington 
University School of Medi­
cine under the guidance of 
Michel M. Ter-Pogossian, 
Ph.D., PET continues to ex­
pand into new applications. 
The Dana Foundation, 
founded in 1950, is a private 
philanthropic foundation 
with assets in excess of $223 
million. Among the found­
ation's commitments is the 
funding of research into 
brain-related disorders that 
affect millions . • 
Kipni~ NUIlIPfl 
ACP lVIa~tcr 
avid H. Kipnis, 
M.D., Adolphus 
Busch Professor 
and former head of the De­
partment of Internal Medi­
cine, has been selected to 
become a Master of the 
American College of Physi­
cians (ACP). 
Masters are ACP fellows 
who - because of renown in 
medical practice or research, 
positions of honor and influ­
ence and personal character 
- are recommended by the 
Awards, Masterships and 
Honorary Fellowships Com­
mittee to the ACP Board of 
Regents. Of the ACP's 
75,000 members, only about 
200 have achieved master­
ship. Kipnis joins Michael 
M. Karl, M.D., who became 
a Master in 1990. The late 
Carl V. Moore was the first 
Missouri physician to earn 
the honor. 
Kipnis was head of the 
Department of Internal 
Medicine from 1973 until 
1992. Regarded as a pioneer 
in diabetes research, Kipnis 
has worked to learn the 
mechanisms of sugar and 
amino acid transport and 
regulation of insulin released 
by islet cel Is in the pancreas. 
He pioneered the application 
of fundamental and biologic 
science to clinical situations. 
Kipnis was deeply in­
volved in the Washington 
University/Monsanto Bio­
medical Research agreement 
- the largest research col­
laboration between an 
American company and an 
American university. It has 
provided nearly $100 miJJ ion 
in research funding. Kipnis 
is also the chairman of the 
Scholar Advisory Committee 
of the Lucille P. Markey 
Charitable Tmst. 
The ACP is a non-profit 
organization of physicians 
trained in internal medicine. 
It includes practitioners pro­
viding primary care, medical 
specialists in cardiology, 
neurology and oncology, and 
medical researchers and 
teachers. 




M aria 1. Donoghue has been selected as the first recipi­
ent of the Barbara Jakschik 
Award, to be presented an­
nually to a senior female 
graduate student in recogni­
tion of outstanding academic 
and research accomplish­
ments in the area of meta­
bolic regulation. The award 
is named for Barbara 
Jakschik, Ph.D., who re­
cently retired from the De­
partment of Molecular 
Biology and Pharmacology. 
Donoghue was among 
those selected as 1992 Spen­
cer T. and Ann W. Olin 
Medical Scientist Fellows. 
Also named as fellows were: 
Stanley T. Cannichael, 
Jonathan N. Glickman, 
Howard P. Goodkin, 
Michelle L. Hermiston, 
Randall R. Johnson, Gregory 
Joslin, Susan E. Koester, 
Brenda Myers-Powell, Tho­
mas M. 1. Niederman, David 
M. Pressel, Christopher R. 
Solaro, Joel S. Solomon, 
Thomas E. Wilson and John 
D. York. 
Recognized for achieve­
ment in biomedical research, 
Olin Fellows look forward to 
outstanding careers in medi­
cally relevant areas of basic 
science. Most are pursuing 
combined M.D'/Ph.D. de­
grees. 
The fellowships are 
funded by a $30 million 
commitment to the Division 
of Biology and Biomedical 
Sciences made in 1986 by 
the Spencer T. and Ann W. 
Olin Foundation. The gift 
supports students in the 
Medical Scientist Training 
Program (MSTP) . • 
1992 Spencer T. and Ann W. Olin Medical Scientist Fellows 
(5eated, left to right): Johnson, Pressel, Glickman, Solaro. 
(standing, left to right): Carmichael, Goodkin, Solomon, 
Hermiston, York, Donoghue, Niederman. Not pictured: 
Joslin, Koester, Myers-Powell and Wilson. 
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Anesthesiology Geb $2 Million 
P.ooglounl Ploject Gl"ant 
Three teams of inves­tigators here will share a program 
project grant to fund studies 
of the mechani sms by which 
general anesthetics produce 
their effects. The grant is one 
of two awarded by the Na­
tional Institutes of Health to 
investigate the cellular and 
molecular mechanisms by 
which anesthetics work and 
is worth more tban $2 mil­
lion over five years, with the 
first year award totaling 
$585,000. 
Alex S. Evers, M. D., act­
ing head of anesthesiology, 
calls the grant a recognition 
for groundbreaking research 
being conducted in the de­
partment. "Our efforts to 
better understand the ways in 
which anesthetics work are 
unique in the world today," 
Evers says. 
Although the effective­
ness of various anesthetics is 
6 
well documented, no real 
agreement exists on why and 
how this class of drugs is 
able to make patients lose 
consciousness. The program 
director is Joseph H. 
Steinbach, Ph.D., professor 
of anesthesiology and of 
anatomy and neurobiology. 
He is also the principal in­
vestigator of one project that 
will study the ways in which 
anesthetics increase inhibi­
tion in individual cell s in the 
brain. 
Steinbach says, "We will 
be studying two different 
kinds of receptors in specific 
brain cells to see what it is 
that anesthetics actually do 
at the cellular and molecular 
level at clinically relevant 
doses." 
The second project 
funded by the grant is an in­
vestigation of anesthetic 
drugs that are chemically 
larger than the gaseous anes­
thetics used in surgery. The 
structures of these drugs will 
be modified to learn more 
about the parts of molecules 
involved in producing anes­
thetic effects such as loss of 
consciousness. Douglas F. 
Covey, Ph.D., professor of 
molecular biology and phar­
macology, is principal inves­
tigator. Charles F. Zorumski , 
M.D. , associate professo r of 
psychiatry and of anatomy 
and neurobiology, is co-in­
vestiga tor. 
The tbird project wi II 
study the effects of anesthet­
ics on calcium channels in 
neurons. Christopher J. 
Lingle, Ph.D., associate pro­
fessor of anesthesiology and 
of anatomy and neurobiol­
ogy, will investigate the acti­
vation of calcium channels 
that is required for the trans­
mi ss ion of information be­
tween nerve cell s. Lingle 
will study the ways in which 
anesthetics inhibit calcium 
channels in specific types of 
nerve cell s. 
"The point of all three 
projects is to try to figure out 
what's going on," Steinbach 
says. "The goals are to 
clarify the molecular mecha­
ni sms by which anesthetics 
act and to determine whether 
one cellular or molecular 
action is clinically more rel­
evant than another. In addi­
tion to increasing our 
unders tanding of the drugs in 
current use , the results could 
perhaps lead to the design of 
new approaches for produc­




William M. Landau M.D., professor of' neurology, and 
Alison M. Goate , D. Phil. , 
associate professor of psy­
chiatry and genetics, have 
been honored by the Ameri­
can Academy of Neurology. 
Landau delivered the 1993 
Netter Lectureship and 
Goate was awarded the 
Potamkin Prize for 
Alzheimer' s Disease Re­
search. 
The Frank. H. Netter Lec­
ture, sponsored by CIBA­
Geigy, is awarded for 
excellence as a neuro-educa­
tor involved in clinically rel­
evant research. Landau 
spoke on "The Practice of 
Clinical Neuroskepticism." 
His lecture was based on the 
illustrative case hi story of 
his own patient, whose faint­
ing attack had been attrib­
uted to a condition known as 
carotid s inus syncope. 
This stimulus led to criti­
cal review of the hospital 
record and 60 years of perti­
nent literature . By reason­
able scientific standards, 
Landau maintained, neither 
the diagnosis nor the ac­
cepted understanding of the 
condition is valid. His advi­
sory conclusion regarding 
neurological diagnosis was , 
quoting Finley Peter Dunne, 
"Tru st everybody, but cut the 
cards." 
Goate received the 
Potamkin Prize, which was 
established in 1988 to recog­
nize "major contributions to 
the understanding of the 
causes and the prevention, 
treatment and ultimately the 
cure for Alzheimer 's disease 
and related disorders ." Goate 
is one of four recipients of 
this year's prize. The four 
will share a $100,000 cash 
award. 
Goate is internationally 
known for her di scovery of a 
genetic mutation linked to 
cases of familial Alzheimer's 
disease. That discovery has 
been responsible for a world­
wide refocusing of research 
into Alzheimer ' s disease. 
The two awards were 
made at the American Acad­
emy of Neurology's annual 





 avid Schlessinger, 
Ph.D. , has been 
named president­

elect of the American Soci­

ety for Microbiology (ASM), 





of molecular microbiology 

and genetics and director of 

the Human Genome Center 

at the School of Medicine, 

will become president of the 

society on july I, 1994. 

The ASM, with nearly 

40,000 members , is one of 





Schlessinger and the other 

officers of the ASM oversee 









A geneticist, Schlessinger 

ran for election on a plat­

form that emphasizes the 

promotion of more genome 

work in microbiology. Mi­

crobiology helped spawn the 

era of modern genetics, and 





will have an increasing im­

pact on biotechnology, 

bioremediation and in fec­

tious disease research . • 

l\1.arkfAl' For Survival FUluul (11 
Bl'uin f~anet~r Patients 
R esearchers have found a marker for high survi val rate 
among patients with neuro­
blastoma, one of the most 
common mal ignant child­
hood tumors. 
They report that tumors 
with high levels of expres­
sion of the nerve growth fac­
tor receptor, TRK 
(pronounced "track"), show 
a very favorable outcome. 
"This finding is important 
because it provides a marker 
for good and bad prognostic 
groups," says Garrett M. 
Brodeur, M.D., associate 
professor of pediatrics and of 
genetics. 
The group studied tumor 
samples taken from 77 pa­
tients. Each sample was ex­
amined for the presence and 
amount of TRK receptor and 
was then correlated with 
five-year survival rate. 
Eighty-six percent of pa­
tients with high levels of 
TRK expression had a high 
survival rate . 
Nerve growth factor 
(NGF) is a protein that pro­
motes survival and differen­
tiation of specific nerve 
cells. Developing nervous­
system cell s that give rise to 
neuroblastoma have a choice 
of three fates: I) continue to 
grow, 2) differentiate into 
mature cells and stop divid­
ing, or 3) undergo pro­
grammed cell death. It 
appears that TRK coaxes the 
cells to choose di fferentia­
tion or programmed cell 
death, abandoning the can­
cerous option, Brodeur says. 
Eight years ago , 
Brodeur' s group found N­
myc, a marker for low sur­
vival rate in neuroblastoma 
patients. The short-term im­
pact of these studies is that 
the two markers can give a 
better idea of a patient's 
prognosis. "And it also gives 
us a way to individualize 
therapy and decide who 
should be treated with a 
more aggressive drug regi­
men ," Brodeur says . Patients 
with higher TRK expression 
and low N-myc expression 
might be weaned off chemo­
therapy earlier, he adds. Bro­
deur is hopeful that a 
diagnostic test for TRK will 
be available to all neuroblas­
toma patients in the near fu­
ture. 
The long-term importance 
of these findings is yet to be 
determined, but Brodeur be­
lieves they could lead to 
drug therapy that is less 
toxic than current therapy. 
Kahn Nanlt·.] I)ia-f."('tol' 

Of Met1i('al Infol"lnatics 

M ichael G. Kahn, M.D., Ph .D., assis­tant professor of 
medicine, has been named 
director of the division of 
medical informatics at the 
School of Medicine. The ap­
pointment was announced by 
John P. Atkinson, M.D., pro­
fessor and chairman of the 
Department of Interna I 
Medicine and professor of 
molecular microbiology. 
Kahn's research focuses 
on developing ways to use 
computerized biomedical 
information to solve prob­
lems in medical research and 
patient care. Current projects 
use computer databases for 
clinical decision support in 
quality assurance and infec­
tion control. He also holds 
teaching responsibilities for 
the Training Program in 
Medical Informatics , gradu-
Michael G. Kahil, M.D., 
Ph.D. 
ates of which receive either 
an M.S. or a Ph.D. in com­
puter science or a related 
discipline. The program is 
administered from the Insti­
tute for Biomedical Comput­
ing, a joint department of the 
School of Medicine and the 
School of Engineering. 
I7 
II 
P lastle surgeon Susan E. Mackinnon, M.D., has the nerve to make basic medical research 
count in the lives of her patients. That ' s 
why a teenager named Matthew is 
walking on his own two feet these days. 
Five years ago, Matthew fell off a 
motor boat, and propeller blades struck 
his legs. Because the resulting nerve 
damage appeared irreparable, amputa­
tion of his left foot seemed inevitable. 
His plight illustrated the then-current 
limits of reconstructive surgery. But 
having plumbed the mysteries of nerve 
regeneration and immunology in the lab 
for more than a decade, Mackinnon, a 
professor of surgery, was able to rewrite 
conventional wisdom with a scalpel. 
She convinced Matthew's body to 
accept a nerve graft from someone else 
without a need for lifelong dependence 
on problematic immunosuppressive 
drugs. The implications of this surgery, 
together with the development of nerve 
banks, promise to eliminate the need for 
patients like Matthew to rely on nerve 
grafts from their own bodies - or to go 
without one, period. "All of my re­
search ," says the Canadian-born 
Mackinnon, "led up to this case." 
The particulars of the case were not 
pretty. The propeller blades had mangled 
the sciatic nerve in Matthew's left leg, 
severing it at one point. The sciatic 
nerve is a neural interstate highway, 
running from the base of the spinal cord 
and dividing at the thigh into the 
peroneal and posterior tibial nerves, the 
latter extending to the big toe. All of 
these nerves are classified as peripheral 
because they emanate from the spinal 
cord. 
Besides preventing Matthew from 
moving his ankle and toes, his injured 
sciatic nerve left him with no sensation 
in his foot. He wouldn't be able to feel 
any bodily slights there - like a pebble 
in his shoe. This predicament leads to 
chronic ulceration, infection and , 
usually, amputation. 
The nerve damage was too extensive 
for Mackinnon merely to stitch the two 
severed nerve ends together. She 
needed, in fact, a 23-centimeter length 
of healthy nerve to serve as a graft. 
Mackinnon had performed hundreds of 
nerve grafts before. But the nerve 
Pseudo-color images show the results ofcompression injury. 011 the left, the two components ofnerve fibers appear in a normal 
ratio ofaxon (green) to myelin (red). As a result ofa compression injury (right), the ratio ofaxon to myelin is higher. The 
reduced proportion ofmyelin slows the travel ofinformation along the nerve. 
sections, typically five to 10 centimeters 
long, had been autografts - that is, they 
had come from elsewhere in the 
patient's body. Such procedures unfortu­
nately mean double surgery and rob the 
patient of sensation where the graft is 
harvested, but they succeed . 
Matthew, however, didn't have such 
a long section of nerve that he could 
afford to give up. So why not transplant 
a length of nerve from a donor - an 
allograft - as is done with hearts and 
kidneys? Surgeons have tried doing it 
with nerves since 1878. And they've had 
plenty of incentive. Allografts eliminate 
the injury and scarring that attends the 
harvesting of tissue from the patient's 
body . Plus, they give surgeons greater 
variety in the nerve tissue available for 
transplant. 
But until 1988, nerve allografts had 
been confined largely to the realm of 
wishful thinking. Published research cast 
serious doubt on the possibility of 
bringing severed nerves back to life. 
After all, the body's immune system 
persecutes such foreign tissue. 
To be sure, transplant specialists 
possess a remarkable drug, cyclosporine, 
that suppresses the immune system and 
prevents rejection. But the drug, nor­
mally taken for the rest of a transplant 
patient's life, can produce serious side 
effects including kidney and liver 
damage, hypertension and depression. 
"We can't sign up patients for this 
type of immunosuppressive toxicity if 
we're not saving their lives," says 
Mackinnon. Transplants of nerve 
allografts to restore the use of a foot 
have not warranted a lifetime prescrip-
Plastic surgeon Susan E. Mackinnon, 
M.D., practices peripheral nerve 
surgery at Bames and St. Louis 
Children's hospitals. 
tion of the drug. So, according to 
conventional wisdom, Matthew had only 
a likely amputation to look forward to. 
Mackinnon, however, had been 
conducting research to realign conven­
tional wisdom. A nerve allograft, she 
hypothesized, might be successful with 
only a temporary regimen of 
cyclosporine. Mackinnon launched her 
investigation while on the faculty at the 
University of Toronto and continues it 
here. 
The human nervous system is 
fascinating partly because of its com­
plexity. When a nerve is cut, it's like 
snipping a cable to find that it is com­
posed of many sma lIer wi res. Each one 
of those is a bundle of even smaller 
wires. The nerve bundles are called 
fascicles. The neural wires inside 
fascicles are axons - the essential nerve 
tissue that transmits signals to and from 
the brain. Axons relaying vibration and 
movement signals are sheathed with 
myelin, a protective tissue made by so­
called Schwann cells, Mackinnon 
explains. Axons for pain and tempera­
ture are unmyelinated. Besides produc­
ing myelin, Schwann cells string 
together to form a kind of tubing that 
encloses or supports the axon. 
An individual axon is not a distinct 
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To assess functional recovery after 
nerve injury, Mackinnon and her 
colleagues dip the feet oflaboratory 
animals in developer, then walk the 
animals on X-ray film to record their 
tracks. Here, a rat's left hindfoot is 
normal; the right side displays nerve 
damage evidenced by the long track 
and relatively short toe spread. 
Research assistant Daniel Hunter uses the digital image 
analyzer to assess a histologic slide ofperipheral nerve. 
nerve cell that extends from the cell 
body. An axon that reports a prick in 
your big toe is part of a cell that has 
snaked its way there from the spinal 
cord. If its cell body were the size of an 
average person, the axon would stretch 
for eight miles. 
Cell bodies of nerves that wire the 
body for voluntary and involuntary 
movement are nestled in the so-called 
anterior horn of the spinal cord. Their 
axons sprout delicate endings that form 
synapses with muscle tissue. Cell bodies 
of sensory nerves lie in nerve tissue just 
outside the spinal cord; their axons 
terminate as free nerve endings or 
specialized receptors, like those for 
touch. 
When an axon is severed, the seg­
ment closest, or proximal, to the spinal 
cord will grow unmyelinated feelers that 
seek the outlying, or distal, segment, 
says Mackinnon. At the same time, 
Schwann cells in the distal segment 
proliferate. They give the axon a 
structure to advance along at the rate of 
about one inch per month, and they 
produce chemical factors that encourage 
the axon to move forward. Schwann 
cells also wrap the axon with myelin if 
the axon was originally myelinated. The 
regenerating axon doesn't stop growing 
until it reaches the appropriate muscle 
tissue or sensory outpost. 
Surgeons turn to 
grafts when the gap in 
a severed nerve is too 
long for the axons to 
span. Essentially, a 
nerve graft provides 
the vine-like axons 
with new Schwann 
cells that serve as a 
neural trellis. All of 
this basic neurology 
came into play when 





In one study, 
pieces of sciatic nerve 
were grafted into the 
hind legs of 14 
laboratory rats. The 
The glass knives used to section 
nerves for study via light and 
electron microscopy. 
animals received cyclosporine for eight 
weeks to disarm their immune systems. 
The rats on cyclosporine gained increas­
ing function in their hind legs for eight 
weeks and then slipped in motor 
performance over the next six weeks. 
The reason? The immune system, no 
longer suppressed, was attacking the 
nerve graft and its Schwann cells in 
particular. There also was microscopic 
evidence of rejection - at 14 weeks 
regenerating axons had unusually thin 
layers of the myelin made by the hard­
pressed donor Schwann cells. 
This rejection of the nerve grafts, 
however, was short-lived. After week 14 
of the study, the rats' motor recovery 
was on the upswing. And at 20 weeks, 
the myelin surrounding the axons had 
thickened considerably. The repaired 
nerves were thriving again, says 
Mackinnon, because the rats' own 
Schwann cells - safe from the immune 
system's hostility - were repopulating 
the grafts and fostering axonal regenera­
tion. Only a short course of low-dose 
immunosuppression is required for 
results that equal an autograft. 
Mackinnon has since replicated these 
findings on temporary immunosuppres­
sion and rejection in a larger study 
involving 150 animals studied over 30 
weeks. However, she had enough 
evidence in hand in September 1988 to 
justify experimental surgery when 
Matthew was referred to her for a nerve 
transplant. Several days later, St. 
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Nerves are embedded in epoxy resin 
prior to sectioning. 
Michael's Hospital in Toronto found a 
suitable dono r - a IS-year-old girl 
killed in an auto accident 
"At the time , I was in Ottawa to 
receive an award from the Royal College 
of Phys icians and Surgeons of Canada 
for my research ," says Mackinnon. 
"There I was dressed and ready to go to 
a black-tie dinner. I caught the first 
plane to Toronto . It was all very 
rushed. " 
The surgery succeeded, but Matthew 
has not regained motor function in his 
left foot. That's predictable, says 
Mackinnon. "Sensory receptors will wait 
pretty much forever to be reinnervated, 
but muscles are under a time clock. We 
have to reinnervate them before a 
particular time, or they won't work." 
Still, Matthew can move his left leg well 
enough to walk. Most importantly, his 
left foot can feel a pebble, a bee sting or 
a tuft of grass , even though cyclosporine 
treatments stopped in 1990. 
"He thinks it 's pretty much like his 
normal foot, although he does wear an 
ankle brace and limps a little ," says 
Mackinnon. "He rides his bike, plays 
baseball and walks barefoot on the 
beach. He's as happy as he can be." 
Mackinnon hopes to capitalize on the 
feasibility of nerve allografts by devel­
oping nerve banks for their storage. She 
and her research fellows in Canada have 
found that animal nerve grafts refriger­
ated for up to three weeks work as weJl 
as fresh grafts. Plus, chilling the donor 
tissue appears to cool the body's 
immunological ire. The laboratory here 
continues to work on the many aspects 
of nerve a llografts - from regulating 
the immune response to methods for 
sto ring nerves as transplant material. 
In Matthew's case, when a donor 
graft became available, Mackinnon had 
to operate immediate ly. A nerve bank 
would eliminate the haste. "We will 
have more time to get a better histocom­
patibility match between donor and 
patient. We can test for viruses in the 
gra ft in a more controlled fashion. The 
nerve bank lets us make transplantation 
an elective procedure instead of an 
emergency procedure , which will lower 
the cost," Mackinnon says. "Many 
patients will benefit from this . It may 
take 10 years to get a nerve bank going, 
but we will." 
Mackinnon the surgeon operates on 
approximately 400 patients a year, all of 
them with damaged peripheral nerves. 
Her patient Matthew remains the 
world's only successful recipient of a 
nerve allograft. To Mackinnon, situa­
tions like his demand more communica­
tion between neurological researchers 
and surgeons, both of whom occasion­
ally have functioned 
like loose ends of a 
severed nerve. 
"Peripheral nerve 
surgery is being done 
by plastic surgeons , 
orthopedic surgeons, 
neurosurgeons, 
general surgeons , you 
name it. It fi ts into so 
many spec ialties that 
it hasn't developed a 
niche yet," she says. 
"Patients with these 




element will be the 
neuroscience, 
Mackinnon believes: Doug Ball (foreground), a student in the M.D.lM.A. 
"Neuroscientists are program, and Catherine Gilliam, M.D (backgrollnd), a 
among the purest of resident in plastic surgery, conduct research in 
the basic scientists. Mackinnon's lab. Ball studies the effect ofage on periph­
They have a lot of eralnerve regeneration. Gilliam works on a variety of 
infonnation we projects in the hope ofestablishing a nerve bank for future 
human transplantation. 
Work by Yasushi Nakao, M.D., Pit. D., 
and Catherine Gilliam, M.D., in 
Mackinnon's laboratory cOllcentrates 
on using antibodies to prevent tlte 
immune system from attacking a 
transplanted nerve. When highly 
specific T-cell receptors are blocked by 
the antibodies, a nerve graft is accepted 
without systemic side effects. 
surgeons can extrapolate for our patients 
with cut-up nerves - if we can speak 
their language, if we can get into their 
literature. I want to be a liaison between 
the two groups." 
Or a graft, if you will , of medical 




by Jim Keeley 
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brain performs a task that 
today's best supercomputers can't 
equal. And you don't even realize it 
is happening. The wiring, circuits 
and switches that crisscross your 
brain underlie an information net­
work that takes in visual informa­
tion and makes sense of it without 
your having to think about it. 
s you read these words, your 
,e 
Learning How We See 

Scientists delving into the 
process of how we see have 
learned that there's more to vision 
than meets the eye. So much 
information floods our eyes that 
the retinal ganglion cells - the 
cells at the back of the eye that 
transmit electrical signals to the 
brain - prune away nearly 99 
percent of it before the brain even 
begins to process the image. 
Nearly 99 percent of the informa­
tion is lost and still we can see. 
How is that possible? 
This is the sort of question that 
gets the attention of David C. Van 
Essen, Ph.D. His appointment as 
Edison Professor of Neurobiology 
and head of the Department of 
Anatomy and Neurobiology has 
thrust the School of Medicine into 
the middle of one of the hottest 
debates in neuroscience: How 
does the human brain process and 
make sense of visual information? 
Van Essen suspects that the 
brain is more complex than the 
most powerful computer humans 
are capable of developing. But, 
provocatively, he believes that 
man-made computers may be the 
key to deciphering the compli­
cated information networks that 
distinguish the human brain. Computa­
tional neuroscience, as this branch of 
science is called, is a relatively new field 
that combines researchers' ideas and 
David C. Vall Essell. Ph.D., views a large. physical 
model ofa macaque's braill, with the areas dedicated 
to l,isual processing highlighted ill various colors. 
intuition with experimental evidence and 

computer power to crack the code of the 

ultimate computer, the human brain. 

Van Essen is one of the field's founders. 

Seeing and Recognizing 
Dwelling on the few millisec­onds that occur between 
seeing and recognizing is not 
easy, but Van Essen has learned 
from the best. As a postdoctoral 
fellow in the Harvard University 
laboratory of David Hubel and 
Torsten Wiesel , Van Essen helped 
two future Nobelists open a new 
window on the brain. "They 
showed that one could glean 
remarkable insights about the 
properties of individual nerve 
cells and how those cells respond 
to visual stimuli ," Van Essen 
says. "It was tremendously 
exciting in the 1960s and 1970s to 
finally understand some of the 
initial stages of processing in thc 
visual cortex." 
Hubel and Wiesel won a Nobel 
Prize in Medicine or Physiology 
in 1981 for demonstrating that 
cells in the visual cortex respond 
selectively to stimuli, such as 
bars, edges of light and direction 
of motion. They showed the brain 
at work, analyzing minute regions 
of the visual world for character­
istics (such as shape, contour, 
motion and orientation) and 
assembling that information into a 
coherent picture - the process \Ne call 
seeing. 
13 
Three computer-generated reconstructions ofthe macaque brain. On the left, 85 two-dimellsional COlltOUrs have been stacked 
and connected by computer into 120,000 triangles. In the center, the triangles have been filled in to form a continuous Sill/ace, 
thereby providing a view down into the folds, or sulci. The reconstruction is by ussistunt research scientist Heuther Drury, M.S. 
On the right, the computer hus recorded the positions ofcells labeled by u tmcer illjected into a distunt ureu ofthe bmin.. The 
labeled cells ure displayed in u three-dimensional reconstruction ofthe cerebral cortex's gray matter. 
From that work, scicntists subse­
quently showed that visual process ing is 
the product of a series of lightning-fast 
steps that take place in di stinct areas of 
the brain. Neurons reccive the initial 
signals and respond to simple patterns, 
such as anays of light and dark bars. As 
raw information about what the eyes are 
focused on moves through successive 
level s in the brain, specialized cells filter 
the information. A t the final stagcs, all 
of that information is meshed togcther, 
and we recognize an object. Though 
Hubel and Wiesel provided a fresh 
perspective on the initial stages of visual 
processing, researchers remained largely 
in the dark about how cells that respond 
to specific stimuli work together to 
process complex images and form a 
smooth, unbroken picture of the world. 
That was the problem Van Essen 
wanted to solve. instead of focusing on 
the primary visual cortex, he concen­
trated on higher levels of the brain ­
areas where complex images are 
decoded and recognized. The techniques 
that Hubel, Wiesel and others had 
developed for exploring the visual brain 
Ed Connor, Ph.D., II poslifoctoral fellow, tests the responses of imlividuailleurons 
to a "uriety of" I'i.mlt/ stimuli as the animal ultemls to dlfferentlocatiolls on a 
computer screel/. 
were important, but it became clear to 
Van Essen and others in the 1970s that if 
they were to see how thc brain organizes 
the flow of information and forms an 
unbroken picture, new tools would be 
required. 
And computational ncuroscicnce was 
born. Before therc was such a field, 
there was a group of scientists who fclt 
that the lack of strong mathematical 
formulations and models was a great 
barrier to undcrstanding visual process­
ing. Fortuitously, just as this ficld of 
neuroscience was beginning to take 
shape, the computer revolution was 
occurring. Van Essen and others began 
to view the computer as a valuable ally. 
Today, the computational group is still a 
minority of neuroscient,ists, but their 
theories and data are rapidly overturning 
long-held notions about the brain. For 
cxample, the theory that the brain is 
neatly partitioned - one area for color 
vision, one area for depth perception ­
is giving way to a more flexible descrip­
tion that says these different functions 
may be intertwined. 
Interconnections 
V an Essen's seve ra l research projects may seem discrete to the outsider, 
but they are richly interconnected. In 
that sense, they mirror the organ he is 
studying. The three categories of 
projects - anatomical, physiological, 
and computer modeling - are all 
designed to extract information about 
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the visual system. Experimental work 
uses macaque monkeys. Although it is 
10 times smaller than a human brain, the 
macaque ' s brain nonetheless displays a 
striking similarity to a human's. 
At the turn of the century, classical 
anatomists had identitied three distinct 
areas in the brain responsible for visual 
processing. This model persisted until 
well into the second hal f of this century. 
In 1979, Van Essen wrote a review 
article describing visual areas in the 
cerebral cortex - only six had been 
identified at the time. "It wasn't really 
until the 1980s that there was an 
explosion in the number of identified 
areas," Van Essen says. A current tally 
shows a mind-boggling 32 distinct but 
interconnected areas in the macaque 
brain responsible for interpreting and 
assembling the macaque's visual world. 
Having to keep track of detailed 
experimental data on each of the 32 
areas is overwhelming, Van Essen says. 
Scientists now believe there may be as 
many as 40 visual areas in the macaque 
brain, and" Van Essen hopes there aren ' t 
many more. One goal of his work is to 
identi fy all of them. As each visual 
hotspot is isolated, researchers tease out 
the neuronal wiring that connects one 
area to another. Knowing where the 
visual areas are and how they communi­
cate provides a source of infornlation for 
the group's attempts to build a computer 
model of visual attention . 
Charles H. Anderson , Ph.D., research 
professor of neurobiology, and 
predoctoral student Bruno Olshausen are 
developing a computer model that 
replicates as many of the human visua l 
processing system ' s functions as 
poss ible. They have success fully taught 
a computer to discriminate and recog­
nize a specific letter from a field of 
letters surrounding it. Faithful to the 
brain's actual method of opcration, the 
system tests theories of visual attention. 
Anatomical data also feed the 
voracious appetites of various national 
and international brain-mapping projects 
that are hungry for more detail. Lately, 
neuroscienti sts have promoted building a 
computerized brain map database. The 
computational natu re of Van Essen 's 
work makes him a logical apostle of the 
• 1 
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Van Essen alld his colleagues Iral'e 
summarized what is kllown about the 
305 pathways tlrat interconnect tire 32 
distinct cortical areas ofthe macaque 
brain associated with I'isuai processillg. 
This "wiring diagram" depicts tire 
hierarchy ofthe visual areas and tlreir 
interconnections. (Reproduced with 
permi ss ion, from Science , "Information 
Processing in the Primate Visual System: An 
Integrated Systems Perspective. " Vol. 255. page 
421 , January 24,1992 , © AAAS .) 
brain-mapping initiative. And, in fact, he 
has been working on several paraliel 
projects that will make data on the visual 
system more manageable and accessible. 
The first is a graphical database that 
wi,li allow scientists and students to ask 
better questions about the visual system 
more effectively and more efficiently. 
Such an on-line brain map would hold 
the latest information about any area of 
the visual brain. A researcher wanting 
the current thinking about the pulvinar 
nucleus, a small structure that some 
scientists be lieve is the "consciousness 
command post ," could click his 
computer's mouse on the pulvinar 
nucleus and a torrent of information, 
from journal articles to experimental 
protocol s, would become available. Van 
Essen's team also is assembling a 
detailed map o f the macaque brain on 
high-resolution graphic computers. 
Computers might help resolve 
another issue confronting neuroscien­
tists. Insights gleaned from studying the 
macaque visual cortex bave been 
relevant to what goes on in the human 
brain, Van Essen says , but there has 
been difficulty in precisely comparing 
functions in the two brains. Though the 
human brain is 10 times larger than the 
macaque's, researchers can ' t make a 
direct comparison simply by enlarging a 
monkey brain to the size of a human 
brain, Van Essen notes . Part of the 
solution may come from his collabora­
tion with Michael Miller, professor of 
electrical engineering, to use "warping 
algorithms," sophisticated computer 
programs that aUow one brain to be 
warped into the shape of another. 
Warping algorithms also will be valu­
able for physicians comparing the brain 
of an ill patient to that of a normal 
person, since no two human brains are 
identical. 
It is only fitting that in Van Essen's 
lab much energy is devoted to under­
standing the behavior of small groups of 
neurons in the visual system, a la Hubel 
and Wiesel. These investigations - Van 
Essen labels them "physiological 
studies" - allow scientists to discern 
the idiosyncrasies of small populations 
of neurons within a larger visual area. 
Many different patterns have been 
used to probe the visual system. The 
premise is that if you find the right 
stimulus and present it to a monkey 
during testing, the neurons that respond 
selectively to that visual stimulus will 
sing out. The goal is to explore re­
sponses to different stimuli. If research­
ers use patterns that are too complex, 
such as a picture of a face or a hand , 
cells may respond, but there is no way to 
interpret accurately what component of 
the image those neurons are responding 
to. 
In fact, a subset of cells in the 
temporal lobe responds to complex hand 
and face patterns. "That tells you that 
you are probably on the right track for 
finding cells involved in complex 
pattern recognition. But the question of 
how those cells attain their propcliics is 
very difficult to decipher. You can't take 




its component parts and systematically 
evaluate the relative contributions of 
those parts in a well-controlled way." 
Recent work by Van Essen and post­
doctoral fellow Jack Gallant, Ph.D., 
hints at the existence of a group of cells 
that may serve an intermediate role in 
the recognition of complex patterns. 
Sticking with the dictum that the best 
stimuli to use are well-detined math­
ematical shapes, Gallant convinced Van 
Essen to try an experiment using 
concentric rings and spiral shapes as 
stimuli . Initially skeptical that such 
studies would prove fruitful, Van Essen 
gives Gallant much of the credit for their 
findings . 
The work, which recently appeared in 
the journal Science, shows that cells in 
area V4 of the brain show a striking 
degree of responsiveness to concentric 
rings or spiral shapes. Van Essen is 
fascinated by the finding because it may 
offer a lead to reaching his elusive goal 
of understanding how complex images 
are recognized. "Our hypothesis is that 
these cells are an intermediate stage on 
the way to more complex pattern 
recognition," Van Essen says. 
At the intuitive level, this thinking 
makes sense, he notes, because in the 
natural world there are many structures, 
like flowers, that are dominated by 
Postdoctoral fellow Tom Coogan, Ph.D., 
collects data from brain section.'i with a com­
puter-driven microscope. 
the entire cerebral cortex," Van 
Essen says. 
Many maladies attack the computer 
within - strokes, tumors, epilepsy and 
psychiatric disorders among them. But 
"Polar gratings" are used by postdoctoral fellow Jack Gallant, Ph.D., to test the 
responses ofsingle neurons in an area ofthe macaque's brain dedicated to visual 
information processing. The response ofthe single neuron represented here ranges 
from none (dark blue) to vigorous (red). The cell being tested was highly selective 
for a restricted group ofsimilar patterns. 
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concentric patterns. Concentricity 
may be one of the necessary and 
proper stimuli that neurons in V4 
respond to in order for higher 
level brain structures to recognize 
a flower. The group plans to 
explore further classes of stimuli 
that they think also may contrib­
ute to subsequent stages of visual 
processing. 
Although this branch of 
neuroscience is extremely young, 
Van Essen hopes that the ideas 
wi II one day move out of the lab 
and into everyday use. Under­
standing the brain and its visual 
system from many different 
perspectives may have enormous 
benefits. One example: The wide­
angle approach Van Essen and 
his colleagues take may turn up 
general organizing principles that 
are at work throughout the brain. 
"We study the visual cortex not 
simply for a fascination with 
vision, but with the realization 
that it is an excellent model for 
the organization and function of 
the complexity of the system may be our 
saving grace. The work of Van Essen 
and others challenges the long-held 
notion that the brain compartmentalizes 
its functions, one function per area, like 
today's computer systems. The evolving 
principle is that, instead, many func­
tions are intertwined to create a fast, 
faithful and flexible system. As Van 
Essen says: "The relationship between 
functions and partitions in the brain is 
complicated, because the system has a 
distributed workload. All reg,ions of the 
brain are specialized to some degree, but 
they are not overspecialized." Devel­
oped with these organizing principles in 
mind, the computers of tomorrow may 
edge closer to the powers of the brain . • 
The National Council 
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by Steve Kohler 
ncreasingly, medical 
science's advances are the 
result of interdisciplinary 
collaboration. The complex­
ity of the issues addressed by 
modem medicine demands 
that microbiologists, immu­
nologists, radiologists, sur­
geons - scientists and 
clinicians of every stripe ­
work together to blend ex­
pertise, approach and experi­
ence. The issues confronted 
by medical school adminis­
trators are no less convoluted 
and thorny. 
h"~ ' 17 J 
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William A. Peck, M.D., executive 
vice chancellor and dean of the School 
of Medicine, has tapped the school's 
long history of productive collaboration 
to assist him in steering the institution 
through waters that get choppier as the 
wind level surrounding healthcare , 
research and educational issues rises. 
The medical school's National 
Council was formed three 
years ago to "advise and 
counsel," in Peck's words. An 
august body of 24 prominent 
men and women from a broad 
assortment of endeavors, the 
council now meets twice each 
year to consider the medical 
school's direction. Indeed, the 
university's overview of the 
National Councils says, "The 
purpose of the Councils is to 
monitor, offer advice, 
assistance and criticism to the 
dean and other administrative 
officers .... " 
The councils were estab-
I ished by the Board of 
Trustees in May of 1986 as a 
result of the recommendations 
of the Commission on the 
Future of Washington 
University. Currently, there 
are nine National Councils: 
Seven serve schools of the 
university; one offers advice 
concerning Olin Library, and 
one advises on the issues of 
student affairs. 
The medical school's 
National Council looks at the 
biggest picture: the goals and 
missions, plans and processes 
of the medical school , not the 
details of curriculum or 
budget that many other 
visiting committees address, 
Peck explains. 'The National 
Council has allowed me 
access to individuals who are 
highly intelligent, experienced and 
wise, as well as being enthusiastic 
about our institution," Peck says. 
"Among our members are those who 
are knowledgeable about aJl medical 
schools, not just this one, and people 
with an awareness of the community 
from both a regional and national 
perspective. And I haven't been 
disappointed; the group has more than 
fulfilled my expectations," he says. 
Much of the responsibility for the 
group's efficacy, according to Peck , 
lies with its chairman, Robert 1. Glaser, 
M.D. " Few people are as knowledge­
able about medical schools and aca­
demic medicine," Peck says. Glaser, 
who was on the Barnes Hospital house 
National Council member Charles F. Knight makes a point 
about the medical school's jitlure as part ofa jilll-service 




Robert J. Glaser, M.D., chairman ofthe National Council, 
engages in discussion with William A. Peck, M.D., executive 
vice chancellor and dean of the School ofMedicine. 
staff and began his academic career 
here , has been dean of Colorado and 
Stanford medical schools and acting 
president of Stanford. He has served as 
a trustee of Washington University 
since 1979 and has held executive 
positions in three major, medically 
oriented foundations for a total of 
almost 25 years. 
Glaser points out that the council is 
"not a governing board; we have no 
veto power. But it brings together 
interes ted and knowledgeable people 
from many facets of society to advise 
the administration. Some are business 
leaders, others are active in healthcare, 
and several are well-known academi­
cians. This multidisciplinary approach 
lets each of us focus on the 
details about which he or 
she knows something." 
Glaser applauds the medical 
school for its active role in 
"confronting the complex 
healthcare issues that 
involve our society." 
National Council member 
Raymond H. Wittcoff says 
the issues under consider­
ation are very complex. A 
uni versity trustee, past 
chairman of the board of 
Jewish Hospital and of the 
Medical Center, a successful 
developer of major office 
buildings and a director of 
the Equitable Life Assur­
ance Society, Wittcoff says 
that in a comparison 
between the Medical Center 
and the corporate world he 
inhabits so successfully, he 
finds the business world 
relaxing. 
"We live in a time when 
there's much discussion 
about what's wrong with 
America, and we do have to 
make some fundamental 
changes," Wittcoff says. 
"But the success of our 
great research institutions 
and this medical school in 
particular is gratifying. 
Their preeminence is 
indisputable. We are not 
lagging behind any other 
nation." 
Council member 1. Jerome FIance, 
M.D., a 1935 graduate of the School of 
Medicine, a professor of clinical 
medicine and the recipient of the 
Alumni/Faculty Award and the 
university'S Founders Day Award, sees 
his role on the council as that of friend. 
"Our role is as a sounding board," 




dissent, we counsel. We are friends, quality, integrated healthcare system Barnes, Jewish, Inc. (BJI), pointing out 
there to offer constructive help, though that offers a full range of services and a that in order to be successful, any such 
if we saw something terribly wrong competitive price. Such a full-service system must be seamless, without a gap 
going on we would say so. But that's system will offer everything from in its abilities. Glaser observed that 
not the case now." ambulatory and home-based care to the ridding the current healthcare system of 
Although Peck consults with kind of tertiary and quaternary care its duplication of services - all deeply 
individual council members regularly provided by the super-specialists of the ingrained -- will be among the sticking 
and carefully heeds the council's School of Medicine. points to reaching a new, more efficient 
advice, much of the information during Commenting on Peck's presentation, form of national healthcare. 
the first five meetings The challenge Wittcoff 
flowed from administrators sees is for the medical 
and key faculty to council school to maintain its 
members, according to NAllONAL COUNCIL MEMBERS character as a great re­
Glenda Wiman, assistant search institution while 
dean for special programs taking on an expanding 
William A. Anders Stanley L. Lopata 
and the person responsible clinical responsibility. "I'm 
Falls Church VA St. Louis MOfor arranging the meetings. confident it can be done," 
However, at the most recent Edwin L. Arzt Margaret E. Mahoney he said. "There need be no 
meeting, held in early May, Cincinnati OR New York NY conflict between cost 
councilors more actively control and quality control. Urban Bergbauer Richard J. Mahoney discussed issues faced by the The same leadership that St. Louis MO St. Louis MO
medical school. controls costs may be the 
In the early meetings, the Robert Drews, M.D. James S. McDonnell, III kind that promotes quality. 
counci I learned about and St. Louis. MO St. Louis MO I am more optimistic right 
visited each of the affiliated now than at any other time John P. Dubinsky Daniel Nathans, M.D. hospitals, heard presenta­ during the 25 years I've 
St. Louis MO Baltimore MD tions about major research been watching these 
and construction projects I. Jerome Fiance, M.D. Andrew E. Newman institutions." Both Wittcoff 
either underway or planned St. Louis MO St. Louis. MO and Glaser express great 
and was brought up to date admiration for Peck's 
Ira C. Gall, M.D. Mary Dell Pritzlaff
concerning medical school leadership skills and for his 
St. Louis MO Santa Barbara CA
and Medical Center history. ability to handle effectively 
At meeting number six, Helen H. Glaser, M.D. The Honorable the burdens of his office. 
attention turned to the Athertoll CA Paul Rogers Peck returns the compli­
clinical future of the Washington DC ment: "The National Robert J. Glaser, M.D. institution and the serious Council members have (Chairman) Harvey Saligman issues facing all healthcare been a tremendous asset for 
Atherton CA St. Louis MO
entities. Peck told the group me as a leader, and it would 
about developments at the Charles F. Knight Raymond H. Wittcoff be hard to replicate their 
medical school and its St. Louis MO St. Louis MO assistance in any other 
affiliated hospitals, then way." Council members 
Donald E. Lasater Roma Broida Wittcoffpresented his Knight and John P.St. Louis MO St. Louis MO
administration's vision of Dubinsky, in fact, have 
the post-healthcare reform Lee Liberman Mitchell Yanow, M.D. been instrumental in 
future. He spoke of coming St. Louis MO St. Louis MO realizing BJI and in 
problems for funding bringing about the affilia­
academic health centers, of tion of the Christian 
increased competition for hospitals. 
market share, of the impend- With Peck steering and 
ing dominance of managed care Wittcoff called the opportunity "awe­ the council members advising and 
(represented by the health maintenance inspiring." He said, "We're moving watching for obstacles, the hope and 
organization, or HMO) and of the into an arrangement that I didn't expect the plan is that the School of Medicine 
inevitability of competition between until the next century." Lengthy and wi II be transformed and brought 
I 
Ii 
providers being managed by a govern­ candid discussion followed, with smoothly through the rough passage I 
mental agency, either state or federal. counci I member Charles F. Knight, ahead. On the other side lies continued 
Most im portan tly, Peck deta iled the chairman of the board and CEO of preeminence as a research institution 
0ppoliunity facing the Medical Center Emerson Electric Co., chairman of the based on broader support from greatly 
to direct its own evolution into a top- board of Bames Hospital and of expanded clinical activities . • 
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andra Gray cries every time she 
talks about her father and brother. 
Seventeen years have elapsed since 
their deaths, but time hasn't dulled the pain 
of their passing. Nor has it erased from the 
family's bloodline the rare illness that claimed 
then1 and continues to stalk the S1. Louis won1an, 
her children and other merrlbers of her family. 
The disease, multiple endocrine neoplasia type 2, or 
MEN 2, can traverse generations, quietly passing from 
parent to child. The genetic illness, which causes a specific 
cluster of diseases, has been traced to Gray's father's family. 
BY KLEILA CARLSON 

Sandra Gray and her daughter Gia, 
along with other members of the 
family, have battled MEN 2A, a rare 
but virulent form ofcancer. Gia still 




Like her father and brother, Gray calTies 
the gene for a specific type of the 
disease known as MEN 2A, a disorder 
that can cause medullary thyroid cancer, 
pheochromocytomas (or tumors of the 
adrenal gland) and hyperparathyroidism 
in people between the ages of five and 
45 years. 
Gray's father and brother had both 
medullary thyroid cancer and 
pheochromocytomas, which about one­
third of MEN 2A sufferers develop. 
After their deaths, extensive tests were 
run on Gray, her siblings and others 
from her father's family. Gray, who was 
found to have a pea-sized tumor on her 
thyroid, had the gland removed in 1977; 
tumors also were discovered in her 
younger brother and half-sister by her 
father's previous marriage. Since that 
time, a nephew, several aunts, uncles 
and many cousins also have had tumors 
removed. 
Gray is still tested yearly for the 
development of pheochromocytomas, 
which can cause hypertension and 
sudden death, but she is most concerned 
for her children. In May, her youngest 
daughter, Gia, 19, was found to have a 
tumor on her thyroid. The gland was 
removed at Barnes Hospital in June. So 
far, Gray's three other children, who 
range in age from 17 to 25, have been 
disease-free. "Every time the kids get 
sick, I watch for symptoms (of MEN 
2A)," says Gray. "I get very detailed 
about asking them how they're feeling. 
Even though all of them have been 
tested since they were smaLl, I was 
stunned when they told us Gia needed 
surgery. 
"When you're not in pain, it's hard to 
believe there's something wrong with 
you. The scary thing about medullary 
thyroid cancer is its silence - you may 
not know you have it until it's too late." 
SPEAKING OUT 
Attempting to better unde.. rstand the d isease is Samuel A. Wells .lr., M.D., 
Bixby Professor of Surgery and chair­
man of the Department of Surgery, who 
has spent a quarter century tracking this 
quiet killer that strikes its victims in 
their prime. Wells and his research 
group test and monitor about 2,000 
people in 48 states and several foreign 
Ali B. Linda B. Mark B. Lila R. Kathy R. 
Jim T. 
A family pedigree traces the path ofMEN 2A. Darkened figures indicate disease 
gene carriers. This pedigree presents a classic example of the transmission ofa 
dominant disease gene. 
countries with four different hereditary 
endocrinopathies: MEN 1, MEN 2A, 
MEN 2B and familial medullary thyroid 
carcinoma (FMTC). 
One of a handful of physicians and 
scientists worldwide studying MEN 2A 
and its associated syndromes, Wells 
became interested in the malady about 
20 years ago when, as a surgeon at the 
National Cancer Institute in Bethesda, he 
cared for several patients with the 
disease. Over the last several years, the 
group of investigators working on the 
MEN problem has expanded to include 
pediatricians, pathologists, molecular 
biologists, geneticists, biostatisticians 
and social workers. 
"The ultimate goal is to perform a 
thyroidectomy on these children before 
they develop medullary carcinoma," 
says Wells. "Removal of the thyroid is 
generally well tolerated by children." 
Because MEN 2A is caused by a 
dominant gene, only one copy of the 
defective gene must pass from parent to 
child for the disease to develop. That 
means anyone with an affected parent 
has a 50 percent chance of developing 
the disease. Patients with MEN 2B 
develop medullary thyroid carcinoma 
and pheochromocytomas. They also 
have a typical physical appearance so 
that they are easily recognizable on 
sight. Patients with MEN 2B have a very 
aggressive form of medullary thyroid 
carcinoma, and they often succumb to 
the disease at a young age. Patients with 
FMTC only develop medullary thyroid 
carcinoma. Unlike MEN 2B, patients 
with FMTC have a relatively mild form 
of medullary thyroid cancer. In screen­
ing these fami I ies, every effort is made 
to diagnose the medullary cancer as 
early as possible, since patients can 
often be cured if the tumor is confIned to 
the neck at the time of operation. 
Helen Donis-Keller, Ph.D., director 
of the division of human molecular 
genetics in the Depaliment of Surgery, 
led an effort to identify the gene(s) 
responsible for MEN type 2 syndromes. 
Her laboratory found mutations in the 
RET proto-oncogene in MEN 2A and 
FMTC families. The normal function of 
the protein coded by the RET gene is not 
known at this time. However, it is 
known that the gene is expressed early 
in development and is probably involved 
in the development of neuroendocrine 
cells. 
The RET protein is a member of a 
fami Iy of membrane-spanning tyrosine 
kinase receptors. "We found that the 
DNA mutations cause changes in the 
protein sequence which we suspect alter 
the three-dimensional structure of the 
extracellular domain of the RET 
proteins," says Donis-Keller. "Since this 
region binds a ligand which initiates a 
signaling mechanism, it seems reason­
able that a change in the structure could 
alter this process. One of the next steps 
is to identify the ligand and how it 
interacts with the RET protein so that we 
can begin to understand how the mutated 
protein causes disease." 
Donis-Keller's group has also found a 
mutation in a sporadic case of medullary 
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thyroid carcinoma, leading her to believe 
that RET pl ays a more ge neral role in 
the development of thyroid cancer. 
Although Donis-Keller ex pects that RET 
may also be responsible for MEN 2B, 
the most serious of th e MEN disorders , 
genetic mutations have not yet been 
found. 
" In the MEN 2A and FMTC families 
we are cun'ently studying, we know 
what mutation eac h family carries and 
that everybody in the family has the 
same mutation ," says Donis-Keller. 
"This a Ilows us to do predictive diagno­
sis and determine with high certainty 
who has inherited the mutation for 
disease. Everyone who inherits the 
mutation develops disease." 
Until now, the most reliable test 
available to detetllline disease was the 
calcium-pentagastrin stimulation test, a 
biochem ica l assay in which calcium and 
pentagas trin are given intravenousl y to 
stimulate th e thyroid's secretion of the 
hormon e ca lcitonin. Elevated levels of 
calcitonin are an indication for medul­
lary thyroid cancer. 
Doni s-Keller says the I O-minute test 
is unpleasant, not as accurate as DNA 
testi ng and must be repeated annually or 
semi-annually. "DNA testing can be 
performed early in the lives of these 
people, and the test only has to be done 
once. Thi s will relieve a lot of anxiety in 
people, because we can tell them 
whether th ey carry the disease gene. 
Those who calTY the gene can have 
surgical treatment, because this is a 
completely curable disease if caught 
ear ly." 
ON THE TRAIL 
To catch the disease in its earliest stages, the research group tra vels to 
the remotest of areas and to metropo] itan 
regions to test patients who range in age 
from four years to over 90. Unlike cystic 
fibrosis, which is primarily restricted to 
Caucasians, or sickle ceJl anemia, which 
occurs only in blacks, MEN 2A does not 
di sc riminate on the basis of race . Neither 
is it influenced by sex or geography. 
The excursions began when Wells 
launched his Investi gation into the 
illness with a famil y that came to 
Philadel phia from Western Europe in the 
1700s and ~eltled in the mid-A tla ntic 
states. Onc orthe largest families he 
follows spans the country from Virginia 
to Alaska. Nationwide, he monitors 36 
families with MEN 2A. Members of 
about] 0 different MEN 2A families live 
in Mi ssouri. 
"We spend a lot of time screening 
fam ily members in the field and 
geno typ ing them because they cannot 
come to us," says Wells. " We may 
sc reen a group of 100 people in a 
morning, or we may see only two. 
Sometimes we work in a clinic or an 
office and sometimes from a patient ' s 
home." 
On a recent screening trip to Pennsy l­
vania and Maryland, the living room of a 
patient's home was turned into an 
examination area for 87 family members 
because there was no clinical site 
available. On the same trip just a few 
hours later, families were tes ted in a 
sta te-of-the-art laboratory at the Na­
tionallnstitutes of Health in Bethesda. 
"Other healthcare providers and hospi­
tals have been extremely helpful in 
assisting us during these studies," Wells 
says. 
"A mother, father and three children 
had to be screened, and they had no 
transportation," says Mary DeBenedetti, 
R.N., research nurse and patient coordi­
nator for Wells' research project. 
"Sometimes, we have to accommodate 
the family's circumstances, and we do. " 
DeBenedetti , whose rol e is pivotal to 
the project, plans and coordinates every 
sc reening trip. She is responsible for 
everything from calling patients to set 
appointment times and arrange their 
transpOJ1ation to contacting families to 
log all bil1hs, deaths, divorces and 
disease occurrences. She also tests 
patients and notifies th em of their 
results, and patients tum to her with 
their questions and concerns. 
"This is an uncommon disease, and 
patients need to know they can ca ll us if 
they have questions or concerns," says 
DeBenedetti, who spends more than 85 
percent of her time on the telephone 
keeping tabs on the 93 families in Wells' 
study. "We want them to know we are 
concerned about their health and the 
health of their families." 
Gray's family has taken part in 
Wells' study for the last five years. 
Before that, other St. Louis physicians 
annually tested her fa mil y. "~ I was 
blessed, I think ," says Gray, a second­
grade schoolteacher. ' 'They caught my 
(thyroid) tumor ea rl y, and I didn ' t 
hesitate to have surgery." 
Gray, 49, has been free of disease for 
16 years. She says one benefit of 
participating in a nationwide research 
program is th e education patients receive 
about their illness . "We are apprised of 
the latest research find ings and develop­
ments, and we don ' t forget appointments 
because they call us an d make sure we 
keep them. It' s a ve ry thorough and 
worthwhile program." • 
« 
M{f/J'DeBelletietti. R.N., clJlllIse/~ patient Becky Killian. 1I member (~l("e MEN 211 
study. Killian fwd IIer t/tyroid remoped ill May after 1I fllmor It'OS dis('l1l leretl. 
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Student St 
;\Ialt~1J Dav 1993 
.' 
E arIier this year, ap­proximately four out of every five students 
participating in Match Day 
received a residency position 
at one of their top-choice 
institutions. Ninety-two stu­
dents took part, and 82 per­
cent (75) will be doing their 
postgraduate training at one 
of their top three choices of 
institutions. Fifty-six percent 
will train at their first choice. 
Five students found posi­
tions independent of the 
matching program, and four 
graduating students decided 
not to take residencies im­
mediately. For those taking 
part in the matching pro­
gram, interest in internal 
medicine programs declined 
but remained high, while 
residencies in pediatrics, 
family practice and orthope­
d ic surgery became more 
popular. In 1993, the number 
of new physicians choosing 
to pursue family practice 
(nine) more than doubled 
from last year. Internal 
medicine and pediatrics tied 
for the most frequent choice 
among graduates , with 17 
selecting each; eight will go 
on in orthopedic surgery. 
Forry-one of the new phy­
sicians will remain in SI. 
Louis for their postgraduate 
training, 32 of them at 
Washington Univers ity or 
affiliated institutions. Other 
popular destinations were 
Boston (l 0) , the State of 
California (7) and New York 
(5). The complete list fol­
lows. Some names may be 
listed more than once be­




Univ. of AR for Medical 
Sciences 
011hopedic Surgery 
Gannon, Patrick R. 
CALIFORNIA 
Los Angeles 
UCLA Medical Center 
Anesthesiology 
Kim, Leonard D. 
Internal Medicine - Pre lim. 
Kim, Leonard D. 
Surgery - Preliminary 
Nene, Shriram M. 
Sacramento 
Univ. ofCA-Davis Med. Ctr. 
Surgery 




Fontes , Roger A. 
Pediatrics 
Eichner, Lora K. 
Santa Monica 
Santa Monica Hospital 
Family Practice 
Escobedo, Jodie A. 
Torrance 








Fitzsimmons Army Med. 
Ctr. 
Dermatology 
Wilde , Joseph L. 
DISTRICT OF COLUMBIA 
Washington 
Howard Univ. Hospital 
Surgery 





Kim, David D. 
Jacksonville 
Univ. of FL Health Sciences 
Ctr. 
Radiology - Diagnostic 
Haycocks, Tan G. 
GEORGIA 
Atlanta 




General Surgery - Prelim. 
Solomon, Joel S. 
Ophthalmology 
Steuer, Eric R. 
Augusta 
Medical College of Georgia 
Orthopedic Surgery 
PelJett, Jonathan B. 
ILLINOIS 
Chicago 
Loyola Univ. Med. Ctr. 
Pediatrics 
Pont, Edward A. 
McGaw Med. Ctr.-NW 
Univ. 
Physical Med. & Rehab. 
Cannon, Douglas T. 
Rush- Presbyterian-SI. Lukes 
Internal Medicine - Prelim. 
Levin, Michaell. 
Univ. of Chicago Hospitals 
Pediatrics 
Davis, Michael A. 
INDIANA 
indianapolis 
Indiana Univ. Med. Ctr. 
Pediatrics 
Rosenman, Marc B. 
KENTUCKY 
Louisville 
Univ. of Louisville School of 
Med. 
Surgery 
Grayson, Thomas M. 
MASSACHUSETTS 
Boston 
Boston Univ. School of 
Med. 
Orthopedic Surgery 
Sternenberg, Paul L. 
Brigham & Womens Hosp. 
Internal Medicine - Prelim . 
Champagne, Lynne M. 
Internal Medicine 

Amatruda , James F. 

Ross, Theodora S. 





Match Day results please students Seth Myles (left) and Jay Salpekar. Both will continue their traillillg at Barnes Hospital, 
Myles ill OB-GYN and Salpekar ill psychialry. 
Harvard Mass. Gen. Hospital 
Neurology 
McDonald, Colin T. 
Pathology 




Champagne, Lynne M. 

Simon, David K. 

New England Med . Ctr. 
Pediatrics 

Jaeger, 1enifer L. 

Fischbach, Pete r S. 

St. Elizabeth 's Hosp ita l 
Internal Medicine 
Pound, Darcie K. 
MICHIGAN 
Ann Arbor 
Univ. of MI Hospital s 
Internal Medicine 
Deedy, Matth ew G. 
MINNESOTA 
Minneapolis 
Hennepin County Med. Ctr. 
Family Practice 
Councilman, David L. 
Councilman, Robin M. 
Univ. of MN Hosp. & Clin. 
Internal Medicine 
Crespin, Jeffrey S. 
Radiology - Diagnostic 
Khan , Shireen E. 
Rochester. 





Univ. Hospitals & Clinics 
Family Practice 
Boos, Kathleen A. 
S f. Louis 
Bames Hospita l 
Interna l Medicine 
C hen, Jane 
Faddis, Mitchell N. 
Jac kson, Stephanie L. 
Mi sir, Nahrayshwar D. 
Paranjothi, Subramanian 
Internal Medicine - Prelim. 
McDonald, Colin T. 
Obstetrics-Gynecology 

Kasinak , Claudine M. 





Chough, Leo Y 









Salpekar, Jay A. 

Radiology - Diagnostic 

Butman, John A. 

Surgery - Preliminary 

Carbone, Joseph M. 

Esse lma n, Gregory H. 
Geideman, William M . 
Lin , James C. 
MacDonald , Robe rt R. 
Deaconess Hospital 
Transitiona l 
Moon, Christopher J. 
Jewish Hospital 
Internal Medicine - Prelim. 
Bean, Joseph M. 
N emeth, Patti M. 
Simon , David K. 
Internal Medicine 
Frenc hie , Debra L. 
Radiology - Diagnostic 
Song, Fe lix L. 
St. Johns Me rcy Med. Ctr. 
Internal Medicine 
Markowitz, Scott D. 
Family Practice 
Eppell , Beth A. 
Redmond-Norris, Cecilia M. 
Transitional 

Steuer, Eric R. 
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St. Louis Children' s Hospital 
Pediatrics 

Cantor, Alan B. 

Esselman, Tamara L. 

Hanson, Robin D. 

Mason, John E. 

Plax, Daniel S. 

Pressel, David M. 

Sterkel, Randall S. 

Stoszek, Renata M. 






Levin, Michael I. 





Esselman, Gregory H. 









Univ. ofNE College of 
Medicine 
Family Practice 





Belle, Beverly A. 
NEW YORK 
Brooklyn 
SUNY Health Sciences Or. 
Radiology - Diagnostic 
Patel, Ameet C. 
Mineola 
Winthrop Univ. Hosp. NY 
Internal Medicine - Prelim. 




Zilkha, Naomi L. 
NY University 
Ophthalmology 
Turbin, Roger E. 
Staten Island Univ. Hosp. 
Internal Medicine - Prelim. 
Patel, Ameet C. 
Rochester 
Strong Memorial Hospital 
Surgery 
Belin, Bruce M. 
NORTH CAROLINA 
Durham 
Duke University Med. Or. 
Radiation - Oncology 
Bean, Joseph M. 
Surgery 
Magee, Kendra P. 
OHIO 
Cincinnati 
Uni v. of Cincinnati 
Internal Medicine 
Wright, Maria B. 
Emergency Medicine 
Wright, Stewart W. 
Columbus 
OH State Univ. Hospitals 
Plastic Surgery 
Bridge, Peter M. 
Riverside Methodist 
Family Practice 
Spangler, Mark M. 
PENNSYLVANIA 
Philadelphia 
Hosp. ofUniv. ofPA 
Radiation - Oncology 
Haas, Jonathan A. 
Wills Eye Hospital 
Ophthalmology 
Buerger, Daniel E. 
Pittsburgh 
Mercy Hosp. of Pittsburgh 
Transitional 
Buerger, Daniel E. 
Univ. of Pittsburgh 
Internal Medicine - Prelim. 
Gazzuolo, Debra 1. 
TENNESSEE 
Chattanooga 
Univ. of TN College ofMed. 
Transitional 
Kim, David D. 
Nashville 
Vanderbilt Univ. Med. Or. 
Internal Medicine 
McKinstry, Scott W. 
Orthopedic Surgery 
Talwalkar, Vishwas R. 
TEXAS 
Dallas 






Gray, Joseph M. 

Houston 
Baylor College of Med. 
Anesthesiology 
Carter, James C. 
UTAH 
Salt Lake City 
Univ. of UT Affiliated 
Hosps. 
Internal Medicine - Prelim. 






Gasper, Kirk P. 
Portsmouth 
Portsmouth Naval Hospital 
Pediatrics 
Francoeur, Michele L. 
Orthopedic Surgery 
Sewell, Daniel G. 
WASHINGTON 
Seattle 
Univ. of W A Affiliated 
Internal Medicine 
Cummings, Paul J. 
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The 1993 Reunion Award recipients (seated, Left to right): GeraLd T. Perkoff, M.D. '48 (ALumni Achievement Award); Henry 
G. Schwartz, M.D. (Distinguished Service Award) (standing, Left to right): Edwin W. Salzman, M.D. '53 (ALumni Achievement 
Award); Ernest T. Rouse, Jr., M.D. '43 March (ALumni FacuLty Award); Bernard T. GarfinkeL, M.D. '48 (ALumni FacuLty 
Award); William H. Daltghaday, M.D. (Distinguished Service Award); Burton A. Shatz, M.D. '43 December (ALumni FacuLty 




Joseph M. Davie, M.D. '68, 
is vice president of research 
at one of the country's lead­
ing biotechnology compa­
nies, Biogen, Inc. He is also 
adjunct professor of microbi­
ology and immunology at 
Northwestern University 
School of Medicine and at 
Washington University 
School of Medicine. 
Davie received A.B., 
M.A., and Ph.D. degrees in 
bacteriology from Indiana 
University . Notably , only 
four years after graduation, 
he was named associate pro­
fessor of pathology and mi­
crobiology and director of 
graduate studies in experi­
mental pathology at Wash­
ington University School of 
Medicine. In 1975, be be­
came professor and head of 
the Department of Microbi­
ology and Immunology and 
also professor of pathology, 
positions he held until 1987, 
when he went to Searle & 
Company. 
Former students describe 
him as "a down-to-earth 
teacher with a genius for ex­
plaining the most complex 
topics in understandable 
terms," and "a very special 
person who always made 
time for the people he 
worked with, no matter how 
busy he was." 
Gerald T. Perkoff, M.D. 
'48, is University Curators 
Professor Emeritus, Depart­
ment of Family and Commu­
nity Medicine, and professor 
of medicine at the University 
of Missouri-Columbia. He 
serves as deputy director of 
the Robert Wood Johnson 
Foundation Generalist Physi­
cians Initiative Program. 
Perkoff attended Wash­
ington University and the 
Washington University 
School of Medicine, then 
trained in internal medicine 
at the University of Utah! 
Salt Lake General Hospital. 
He moved to St. Louis in 
1963 as chief of the medical 
serv ice at St. Louis City 
Hospital, becoming profes­
sor of medic ine in 1965. 
From 1968 to 1979, he 
served as founding director 
of the divi s ion of health care 
research and professor of 
medicine, preventive medi­
ci ne and public health at the 
School of Medicine. 
Perkoff repeatedly has 
been honored for his out­
standing clinical teaching, 
both at the University of 
Utah School of Medicine 
and at Washington Univer­
sity School of Medicine. The 
University of Missouri 
School of Medicine desig­
nated him one of the Great 
Men of Medicine in 1981 . 
Edwin W. Salzman, M.D. 
'53, is professor of surgery 
at Harvard Medical School 
and deputy editor of the New 
England Journal ofMedi­
cine. He has combined a ca­
reer as a vascular surgeon 
with research in hemostasis 
and thrombosis, two con­
cerns of surgeons who oper­
ate on blood vessels. 
The son of a graduate of 
Washington University 
medical school (the late J. 
Marvin Salzman, M.D. '29), 
Salzman rece ived the A.B. 
degree in 1950 and the M.D. 
degree cum laude from 
Washington University and 
an honorary M.A. degree 
from Harvard in 1969. 
After his re sidency, 
Salzman climbed on the aca­
demic ladder as instructor in 
surgery at Harvard Medical 
School and the Massachu­
setts General Hospital, 
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reaching the rank of full pro­
fessor in 1972. 
Salzman is described as 
"gentle and thoughtful," "a 
many-faceted person whose 
interests outside of medicine 
extend from opera to sailboat 
racing," and "devoted to his 




Bernard T. Garfinkel, 
M.D. '48, is professor of 
clinical medicine at Wash­
ington University School of 
Medicine and maintains a 
private practice of internal 
medicine. 
Garfinkel obtained his 
M.D. degree from Washing­
ton University School of 
Medicine, then completed 
his internship and served as 
chief resident at Barnes Hos­
pital. From 1951 to 1953, he 
served at the United States 
Army Armed Services 
Graduate School at Walter 
Reed Hospital and spent 
seven months in Korea with 
the Joint Military Study of 
Bacillary and Amoebic Dys­
entery. 
Garfinkel returned to the 
School of Medicine as an 
instructor, moved through 
the ranks as assistant and 
associate professor and at­
tained the rank of full pro­
fessor in 1973. During many 
years of instructing, he has 
become known especially for 
his expertise in teaching 
clinical diagnosis. 
Garfinkel has been de­
scribed as "one of the great 
clinical teachers ," "a fine 
friend ," "a very compassion­
ate clinician whose patients 
love him," and "a person 
with a lot of mental horse­
power under a most benign 
countenance. " 
Ernest T. Rouse, Jr., M.D. 
March '43, associate profes­
sor of clinical medicine, re­
tired in 1989 after 40 years 
devoted to the private prac­
tice of internal medicine. 
He received his M.D. cum 
laude, holding the highest 
academic rank in his class. 
Rouse was a Jackson 
Johnson Scholar through his 
four years of medical school 
and was class president dur­
ing 1942-43 . 
Following graduation, 
Rouse trained at the Mallory 
Institute of Pathology prior 
to serving as captain in the 
United States Army Medical 
Corps, European theatre, 
from 1943 to 1946. 
Following his entrance 
into private practice, Rouse 
became director of the pri­
vate medical service at Bar­
nes Hospital. As a long-time 
member of the clinical fac­
ulty , he has devoted many 
hours to teaching. 
Modest about his own 
achievements, he is perhaps 
most gratified by a tribute 
from a family member who 
designated him "husband 
and father cum laude." Two 
of Dr. and Mrs. Rouse's four 
children are alumni of Wash­
ington University School of 
Medicine. 
Burton Shatz, M.D. De­
cember '43, is professor of 
clinical medicine and direc­
tor of the Gastrointestinal 
Endoscopy Laboratory at 
The Jewish Hospital of St. 
Louis, responsibilities he 
combines with the private 
practice of gastroenterology. 
Shatz received his A.B. 
and his M.D. degrees from 
Washington University . He 
completed internships at 
Jewish Hospital and at St. 
Louis City Hospital before 
serving as a I ieutenant junior 
grade in the United States 
Navy in 1945-46. In 1949, 
he became an instructor at 
the medical school, moved to 
assistant clinical professor in 
1968, associate in 1973 and 
attained the rank of full pro­
fessor in 1984. 
Shatz was the first physi­
cian in the Midwest to 
perform colonscopic poly­
pectomies and to train other 
physicians in this procedure. 
Colleagues describe him 
as a "pioneer in his field ," 
and "very attentive to his 
patients." He has been a role 
model for his family as well 
as his students . Dr. and Mrs. 
Shatz ' s two sons are both 
physicians. Their daughter, 
Amy Sudarsky, earned her 
degree from Washington 
University and teaches at the 
Boston Art Institute. She is 
married to a physician. 
Distinguished 
Service Awards 
William H. Daughaday, 
M.D. , is Irene E. and 
Michael M. Karl Emeritus 
Professor of Metabolism and 
lecturer in medicine. 
Daughaday received the 
B.A. degree and , in 1943, the 
M.D. degree from Harvard 
Medical School. During 
1949-50, he held a fellow­
ship in biological chemistry 
here, working with Carl 
Corio In 1951, he was named 
director of the metabolism 
division, a position he held 
until 1986. In 1975 he be­
came director of the Diabe­
tes Endocrinology Research 
Center and from 1978 to 
1987 he was director of the 
Diabetes Research and 
Training Center. Daughaday 
was named Irene E. and 
Michael M. Karl Professor 
of Metabolism in 1983 and 
emeritus professor in 1988. 
He is best known for his 
discovery of insulin-like 
growth hormones, or so­
matomedins, from which he 
developed a central organiz­
ing concept in modern endo­
crinology. 
Those who have studied 
and worked with Daughaday 
are singularly devoted to him 
and describe him as "a sage 
counselor," someone who is 
"deeply committed to the 
welfare of his students," and 
who has "displayed out­
standing citizenship through­
out his career at the medical 
school." 
Henry G. Schwartz, M.D. , 
is August A. Busch, Jr. Pro­
fessor Emeritus and lecturer 
in neurological surgery. 
He received the B.A. de­
gree from Princeton Univer­
sity and the M.D. degree 
from Johns Hopkins in 1932. 
He spent two years as a fel­
low at Harvard Medical 
School, becoming an instruc­
tor in anatomy. In 1936, he 
accepted a fellowship in neu­
rological surgery here and 
trained with Ernest Sachs, 
beginning a career that led to 
becoming head of the De­
partment of Neurological 
Surgery, a position he held 
for 28 years. 
Schwartz set up a resi­
dency training program that 
is legendary for its rigorous 
standards. Characterized by 
a dual emphasis on research 
and clinical skills, the pro­
gram produced neurosur­
geons trained in surgery, 
basic anatomy and pathology 
and with a background in 
basic or clinical research on 
the nervous system. Many of 
those trained by Schwartz 
have gone on to direct train­
ing programs at other institu­
tions. 
His associates describe 
him as a "model of excel­
lence," and " an avid fisher­
man and lover of nature as 
well as his fellow man ." 
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The Classes Of 1943 

On September 1, 1939, Hitl er opened his blitzkrieg on Poland. That same week, the School of Medicine admitted a new class of 
students. Accelerated because of the ensuing war and the critical need for doctors, those students graduated in March of 1943. 
The class that entered a year later went to school for two summers and graduated in December of 1943. Because they spent so 
much uninterrupted time together, these classes always have shared a special camaraderie that is partly friendly rivalry. A special 
salute to members of the Classes of 1943 who studied and served under such difficult conditions. 
Reunion-goersfrom the Class ofMarch, 1943. (Front row) 
Leonard Kent, Warren Bowersox, Grace Bergner, Deni se 
Quinn, Wilma Shields, A. Paul Naney, Harlan Firminger (sec­
ond row) Ernest Rouse, Jr., Richard Yore, William Seidler, 
James Read, John Arthur, Raymond Charnas, Irvin Mattick, 
Harry Wittler (top row) Carlton Watkins, G. Russell 
Aufderheide, William Klingberg, Dallas Anthony, Henry 
Uhlemeyer, Frank Wi ssmath, David Feldman, Leslie Rose and 
Gordon Todd . 
Reunion-goers ji-om the Class of December, 1943. (Front 
row) Richard Jones, Robert Tichenor, Alva (Ace) Trueblood , 
Louis Gottschalk, Herbert Wiegand , James Vest (second row) 
Saul Silvermintz, Edward Czebrinski , W. Hammond Jones, 
Alvin Goldfarb, Frances Chappell Wilson, William Middleton, 
Terrell Covington, Jr. (third row) Norman Asel , James Cra­
vens, Morris Alex, Thomas Stauffer, Edwin Krebs , Walter 
Kennedy, Burton Shatz, Stanley Moore (fourth row) John 
Eisenhauer, John Wilson, William Miller, David Krebs , Carl 
Woolsey, H. Lawrence Allred, James Tagge, Tod Makley, Ed­
ward Kowert (top row) Harold Walters, Donald Smith, Conrad 
DeBold, Harry Lichtwardt, Jack Ingram, James Haddock, 
Glenn McElroy, Jerry All en, Jr. , and C. Read Boles. Not pic­
tured is David Stadtner. 
rod Makley, M.D. '43 December andFrom the March contingent, Grace Bergner, M.D. 
Virginia Donley, widow ofLeo F.
'43 March, Wilma Shields, M.D. '43 March, and 
Donley, Jr., M.D. '43 December.Denise Quinn, M.D. '43 March. 
30 
Ernest Rouse, Jr., M.D. '43 March, 
and Eleanor Rouse. 
Eleanor Rouse, Elizabeth Danforth, Bernard Garfinkel, M.D. 
'48, and Judith Garfinkel socialize. 
Tom Stauffer, M.D. '43 De­
cember, visits with Nobelist 
Edwin Krebs, M.D. '43 De­
cember. 
Jo Koehler, Matt Becker, M.D. '58, and Glenn Becker share 





Naomi Silverminfz and Saul 
Silverminfz, M.D. '43 December, are 
shown in front ofthe class pictorial 
history. 
David Stabenow, M.D. '68, Penny Shackelford, M.D. '68, 
and Gary Shackelford, M.D. '68. 
, 
Ira Kodner, M.D. '67, Barbara Kodner, W. Hammond Jones, 
M.D. '43 December, and Polly Jones share a table. 
Executive Vice Chancel/or Willam A. Peck, l~.D., presents 
the Alumni Achievement Award to Joseph Davie, Ph.D., 
M.D. '68. 
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Nancy Ebsen and William Daughaday, 
M.D. 
Roger Fontes, Lora Eichner, Robert 
JlI[acDonald, Lynne Champagne, Jonathan 
Haas, Claudine Kasinak and Daniel 
Buerger ab(l' represent the Class of '93. 
Arthur Oberman, M.D. '58 alld RebaDorothy Rillderer pins a corsage on Mardelle 
Oberman.Krebs. 
Carl Woolsey, M.D. '43 December shakes 






Robert MacDonald, president ofthe 
Class of '93, responds to the welcome 
ofhis class into WUMCAA. 
Outgoing president of the WUMCAA, Penny Shackelford, M.D. 
'68, presents the gavel to Barry Siegel, M.D. '69, incoming presi­
dent. 
Henry Schwartz, M.D., 
Patricia Peck and Willam A. 
Peck, M.D., converse. 
Paul Webber, M.D. '78, JefiMilbrandt, Ph.D., M.D. '78, and 
John White, M.D. '78, reminisce at the Thursday night wel­
coming party. 
Audrey Shatz and Burton Shatz, M.D. '43 
December. 
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Cheryl Rucker and Kendra 
Magee, both members ofthis 
year's class. 
Mary Evalyn WUlff and George 
Wul./J, Jr., M.D. '33. 
Allen Pepple, M.D. '33, Russell Blattner, J\1.D. '33, Edlla Sakimoto, Rich­
ard Sakimoto, M.D. '33, alld Eda Sakimoto-Iinuma. 
Stanley Korsmeyer, M.D., and Philip Majerus, M.D. '61, led a 
tour ofa hematology lab in the Clinical Sciences Research Build­
ing. Attending were: Harlan Firminger, M.D. '43 March, Jack 
Ingram, M.D. '43 December, Alex Mueller, M.D. '38, George 
Blankenship, M.D. '38, and Mark Austin, M.D. '83. 
Bitsy Loewenstein and Joseph Loewensteill, J\1.D. 







Carl Denison, M.D. '68, Lynn Taussig, M.D. 
'68, and Vernon Loverde, AI.D. '68. 
John White, M.D. '78, Kathleen Kent and Harold Kent, M.D 
'78. 
Edwin Salzman, M.D. '53, with his wife, Nancy Salzman, his 
mother, Mrs. J. ,11arvill Sa/~man, and his son, David 
Salzman, Ph.D. 
James Hesper and Emily Smith, M.D. '68. 
Robb Ohtani, M.D. '83, Jay Ponder, and Dawn Groten­
Stapleton, M.D. '83. 
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The solemnity alld the joy of graduation day can be read on the faces of Matthew Deedy and Lynne 
Champagne as they take part in the School of Medicine's commencement exercises. On May 14, the 
school conferred II M.D.lPh.D. degrees, two M.D.lM.A. degrees and 83 M.D. degrees. 
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After Jack Watkins' hand was severed and re-attached at the wrist, he told 
his therapists how much he missed his beloved pastime of fishing . Occupa­
tional therapists at the School of Medicine devised an attachment for the 
splint Watkins wore that let him use rod and reel, and he was back fishing 
within two weeks of his injury. That outcome met his functional goals and 
sped his physical and emotional healing. Incidents like this have occurred in 
occupational therapy departments for three-quarters of a century. On May 6 
and 7, the Program in Occupational Therapy celebrated its 75th anniversary, 
tracing its roots to the first program established west of the Mississippi . In 
1919, the first graduating class comprised 10 members. This year, the 
program graduated 73 occupational therapy students. 
